Commodore Capital »

IsoRay shares owned by Commodore Capital

Quarter-by-quarter ownership of IsoRay (CATX) shares owned by Commodore Capital from 13F filings

Historical chart of Commodore Capital investment in IsoRay

Tip: Access up to 7 years of quarterly data

All positions including IsoRay held by Commodore Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in IsoRay by Commodore Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $25M 21M 1.19

More positions owned by Commodore Capital

Merus N V (MRUS)
Vera Therapeutics Cl A (VERA)
Nuvalent Inc-a (NUVL)
Xenon Pharmaceuticals (XENE)
Spyre Therapeutics Com New (SYRE)
Enliven Therapeutics (ELVN)
Vaxcyte (PCVX)
Mind Medicine Mindmed Com New (MNMD)
Alpine Immune Sciences (ALPN)
Arvinas Ord (ARVN)
Rhythm Pharmaceuticals (RYTM)
Cogent Biosciences (COGT)
Pharvaris N V (PHVS)
Celldex Therapeutics Com New (CLDX)
Nkarta (NKTX)

View all positions for Commodore Capital

Top funds holding IsoRay

Deerfield Management Company
Commodore Capital
Marshall Wace
Vanguard Group
Octagon Capital Advisors
Point72 Asset Management
Henderson Group
Sphera Funds Management
Citadel Advisors
Hills Bank And Trust Company
Laurion Capital Management
Silverarc Capital Management
BlackRock
OrbiMed Advisors
Ghost Tree Capital

View all funds holding IsoRay